FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
CONDUIT PHARMACEUTICALS INC. [ CDT ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 09/22/2023 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 09/22/2023 | M(1) | 4,060,250(2) | A | $0.00 | 4,060,250(2) | I | See footnote(3) | ||
Common Stock | 09/22/2023 | J(1)(4) | 45,000 | D | $0.00 | 4,015,250(5) | I | See footnote(3) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Warrants | $11.5 | 09/22/2023 | M(1) | 754,000 | 10/22/2023 | 09/22/2028 | Common Stock | 754,000(6) | $11.5 | 754,000 | I | See footnote(3) | |||
Warrants | $11.5 | 09/22/2023 | J(7) | 45,000 | 10/22/2023 | 09/22/2028 | Common Stock | 709,000(8) | $11.5 | 709,000 | I | See footnote(3) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. Upon consummation of the issuer's initial business combination (the "IBC"), the issuer's shares of Class B common stock were converted into shares of Class A common stock and the shares of Class A common stock were then reclassified as a single class of common stock. |
2. Includes (i) 3,306,250 shares of common stock due to the conversion of the shares of Class B common stock into shares of Class A common stock and then reclassification into shares of Company common stock and (ii) 754,000 shares of common stock, which prior to the IBC were shares of Class A common stock. |
3. Held by Murphy Canyon Acuqisition Sponsor, LLC (the "Sponsor"). Jack K. Heilbron is the President of the Managing Member of the Sponsor. Mr. Heilbron disclaims any such beneficial ownership except to the extent of his pecuniary interest. Mr. Heilbron resigned as Chief Executive Officer and Chairman of the issuer upon the consummation of the IBC. |
4. Immediately following the consummation of the IBC, Murphy Canyon Acquisition Sponsor, LLC transferred 45,000 shares of common stock as consideration for their services to three directors, two of whom had resigned upon consummation of the IBC. |
5. Includes (i) 3,306,250 shares of common stock due to the conversion of the shares of Class B common stock into shares of Class A common stock and then reclassification into shares of Company common stock and (ii) 709,000 shares of common stock, which prior to the IBC were shares of Class A common stock. |
6. Includes 754,000 shares of common stock, which prior to the IBC were shares of Class A common stock. |
7. Immediately following the consummation of the IBC, Murphy Canyon Acquisition Sponsor, LLC transferred 45,000 warrants as consideration for their services to three directors, two of whom had resigned upon consummation of the IBC. |
8. Includes 709,000 shares of common stock, which prior to the IBC were shares of Class A common stock. |
/s/ Jack K. Heilbron, as President of Managing Member of Murphy Canyon Acquisition Sponsor, LLC | 09/26/2023 | |
/s/ Jack K. Heilbron | 09/26/2023 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |